Alyssa Reimer

784 total citations
3 papers, 212 citations indexed

About

Alyssa Reimer is a scholar working on Neurology, Cognitive Neuroscience and Physiology. According to data from OpenAlex, Alyssa Reimer has authored 3 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Neurology, 1 paper in Cognitive Neuroscience and 1 paper in Physiology. Recurrent topics in Alyssa Reimer's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Neurological disorders and treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (1 paper). Alyssa Reimer is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Neurological disorders and treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (1 paper). Alyssa Reimer collaborates with scholars based in United States, Germany and Canada. Alyssa Reimer's co-authors include Leslie M. Shaw, Katrina Gwinn, Roy N. Alcalay, Amy W. Amara, Margaret Sutherland, Penelope Hogarth, Howard Andrews, Jennifer G. Goldman, Peggy Taylor and Paul Tuite and has published in prestigious journals such as Annals of Neurology, Movement Disorders and Journal of Parkinson s Disease.

In The Last Decade

Alyssa Reimer

3 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alyssa Reimer United States 3 177 69 43 31 30 3 212
Silvia Ríos‐Romenets Colombia 5 155 0.9× 40 0.6× 46 1.1× 26 0.8× 27 0.9× 9 221
Linda P. Oosterveld Netherlands 6 147 0.8× 44 0.6× 41 1.0× 17 0.5× 17 0.6× 6 174
Yihua Ma Italy 5 175 1.0× 96 1.4× 32 0.7× 15 0.5× 50 1.7× 10 218
Tien Dam United States 6 133 0.8× 98 1.4× 50 1.2× 14 0.5× 21 0.7× 14 231
Miguel A. Labrador‐Espinosa Spain 8 134 0.8× 64 0.9× 44 1.0× 24 0.8× 29 1.0× 18 207
Shengri Cong China 4 116 0.7× 26 0.4× 41 1.0× 23 0.7× 16 0.5× 4 156
Yusha Cui China 7 134 0.8× 27 0.4× 46 1.1× 16 0.5× 16 0.5× 14 223
Anthony J. Intorcia United States 9 252 1.4× 79 1.1× 52 1.2× 17 0.5× 40 1.3× 18 333
Alexandra Pérez‐Soriano Spain 9 219 1.2× 83 1.2× 73 1.7× 26 0.8× 16 0.5× 14 273
Alexandra Foubert‐Samier France 6 161 0.9× 57 0.8× 53 1.2× 15 0.5× 10 0.3× 7 236

Countries citing papers authored by Alyssa Reimer

Since Specialization
Citations

This map shows the geographic impact of Alyssa Reimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyssa Reimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyssa Reimer more than expected).

Fields of papers citing papers by Alyssa Reimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyssa Reimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyssa Reimer. The network helps show where Alyssa Reimer may publish in the future.

Co-authorship network of co-authors of Alyssa Reimer

This figure shows the co-authorship network connecting the top 25 collaborators of Alyssa Reimer. A scholar is included among the top collaborators of Alyssa Reimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyssa Reimer. Alyssa Reimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Irwin, David J., Christopher S. Coffey, Chelsea Caspell‐Garcia, et al.. (2020). Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease. Annals of Neurology. 88(3). 574–587. 57 indexed citations
2.
Merchant, Kalpana, Jesse M. Cedarbaum, Patrik Brundin, et al.. (2018). A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein. Journal of Parkinson s Disease. 9(1). 31–61. 38 indexed citations
3.
Goldman, Jennifer G., Howard Andrews, Amy W. Amara, et al.. (2017). Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Movement Disorders. 33(2). 282–288. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Ríos‐Romenets Breakdown of academic impact, for papers by Linda P. Oosterveld Breakdown of academic impact, for papers by Yihua Ma Breakdown of academic impact, for papers by Tien Dam Breakdown of academic impact, for papers by Miguel A. Labrador‐Espinosa Breakdown of academic impact, for papers by Shengri Cong Breakdown of academic impact, for papers by Yusha Cui Breakdown of academic impact, for papers by Anthony J. Intorcia Breakdown of academic impact, for papers by Alexandra Pérez‐Soriano Breakdown of academic impact, for papers by Alexandra Foubert‐Samier
Rankless by CCL
2026